Results of Phase 1b Clinical Trial Comparing Trevena’s TRV130 to Morphine Published in the Journal Pain Jun 24, 2014 7:00 am EDT
Trevena Announces Positive Phase 1 Results for TRV734 for Acute and Chronic Pain Jun 23, 2014 7:00 am EDT
Trevena CEO to Present at the 9th Annual JMP Securities Healthcare Conference Jun 18, 2014 7:00 am EDT
Trevena Highlights Phase 2b-BLAST AHF Trial for TRV027 at the European Society of Cardiology Heart Failure 2014 Meeting May 19, 2014 7:00 am EDT
Trevena to Host Conference Call on May 9th to Discuss First Quarter 2014 Financial Results and Recent Highlights May 2, 2014 7:15 am EDT
Trevena Presents Results from Phase 1b Trial of Injectable Analgesic TRV130 at American Society of Pain Annual Meeting May 2, 2014 7:00 am EDT